TY  - JOUR
SN  - 0036-5548
A1  -  Gönczöl Éva
A1  -  Berencsi Klára
A1  -  Kauffman Elizabeth
A1  -  Endrész Valéria
A1  -  Pincus Steven
A1  -  Cox William
A1  -  Meric Claude
A1  -  Paoletti Enzo
A1  -  Plotkin Stanley A.
AV  - restricted
N2  - A canarypox glycoprotein B (ALVAC-gB) recombinant induces human cytomegalovirus-specific neutralizing antibodies and a gB-specific cytotoxic T-lymphocyte response. The priming effect of ALVAC-gB is more efficient than that of the gB subunit in Al(OH)3. Antibodies of IgG2a isotype are induced by ALVAC-gB.
UR  - http://publicatio.bibl.u-szeged.hu/31774/
Y1  - 1996///
TI  - Preclinical evaluation of an ALVAC (canarypox)-human cytomegalovirus glycoprotein B vaccine candidate; immune response elicited in a prime/boost protocol with the glycoprotein B subunit
EP  - 112
SP  - 110
ID  - publicatio31774
IS  - Suppl.
JF  - SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
VL  - 99
ER  -